Has the 6-min walk distance run its course?

Chest. 2012 Dec;142(6):1363-1365. doi: 10.1378/chest.12-1110.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antihypertensive Agents / therapeutic use*
  • Bosentan
  • Endothelin Receptor Antagonists*
  • Epoprostenol / analogs & derivatives*
  • Epoprostenol / therapeutic use
  • Familial Primary Pulmonary Hypertension
  • Female
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Male
  • Phosphodiesterase 5 Inhibitors / therapeutic use*
  • Sulfonamides / therapeutic use*

Substances

  • Antihypertensive Agents
  • Endothelin Receptor Antagonists
  • Phosphodiesterase 5 Inhibitors
  • Sulfonamides
  • Epoprostenol
  • Bosentan
  • treprostinil